Know Cancer

or
forgot password

Study on Thrombosis Therapy in German Cancer Patients


N/A
18 Years
N/A
Open (Enrolling)
Both
Cancer, Deep Vein Thrombosis, Pulmonary Embolism

Thank you

Trial Information

Study on Thrombosis Therapy in German Cancer Patients


Inclusion Criteria:



- patient with cancer and acute deep vein thrombosis and/or pulmonary embolism

Exclusion Criteria:

- life expectancy less that 6 months

- age less that 18 years

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

treatment time on low molecular weight heparin

Outcome Time Frame:

1 year

Safety Issue:

No

Principal Investigator

Axel Matzdorff, Prof.Dr.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Caritasklinikum Saarbr├╝cken, St. Theresia

Authority:

Germany: Federal Institute for Drugs and Medical Devices

Study ID:

DE-Thrombose-NIS-2012

NCT ID:

NCT01559883

Start Date:

February 2012

Completion Date:

July 2013

Related Keywords:

  • Cancer
  • Deep Vein Thrombosis
  • Pulmonary Embolism
  • cancer
  • thrombosis
  • pulmonary embolism
  • anticoagulation
  • low molecular weight heparin
  • Embolism
  • Pulmonary Embolism
  • Thrombosis
  • Venous Thrombosis

Name

Location